Early research suggests a combination therapy, TH07, may outperform traditional hair loss solutions like minoxidil and finasteride.
Up to 40% of women experience noticeable hair loss by age 50, and shedding can occur at any age. Existing treatments, while effective for some, don’t work universally and often come with side effects. Now, a new topical treatment called TH07 is generating excitement due to preliminary study results indicating it could be more effective than commonly used medications.
The Study: Combining Proven Ingredients
A pilot study published in the International Journal of Trichology tested TH07 against individual treatments: minoxidil, finasteride, and latanoprost. Thirty-four men with androgenetic alopecia (male pattern baldness) were given either TH07 (a combination of all three ingredients) or one of the single treatments for six months.
The results were notable: over half (52%) of participants using TH07 reported dense hair growth, compared to significantly fewer in the single-treatment groups. Researchers concluded that the combination therapy improved efficacy compared to individual ingredients.
Why This Matters: Targeting Hair Loss From Multiple Angles
The potential benefit lies in the multi-pronged approach. As Ife J. Rodney, MD, founding director of Eternal Dermatology + Aesthetics, explains, “Generally in medicine, when you treat conditions by targeting different mechanisms, you tend to get a better result than each individual agent.”
Each ingredient in TH07 tackles hair loss differently:
- Minoxidil improves blood flow to the hair follicles.
- Finasteride blocks DHT, a hormone linked to hair thinning.
- Latanoprost promotes hair growth by shifting follicles into the active phase.
This combined effect could address hair loss more comprehensively than single-ingredient treatments.
Caveats and Next Steps
The study was small (only 23 participants received TH07), and one comparison group had very few completers. The research was also conducted by the manufacturer, Triple Hair Inc., raising potential bias. Despite these limitations, dermatologists acknowledge the approach makes sense.
Gary Goldenberg, MD, assistant clinical professor of dermatology at Icahn School of Medicine at Mount Sinai Hospital, stresses, “A larger study is clearly needed to confirm the findings of this pilot study.”
What To Do If You’re Dealing With Hair Loss
While the results are promising, dermatologists advise against self-treating. Hair loss has many causes, and proper diagnosis is crucial. Early intervention is also key: “Don’t wait until it’s too late to do something about it,” advises Dr. Goldenberg. “See your dermatologist at the first sign of hair thinning.”
The bottom line: TH07 shows potential as a more effective hair loss treatment, but larger, independent studies are needed before it can be widely recommended. In the meantime, consulting a dermatologist remains the best course of action for addressing hair loss concerns.
